Navigation Links
Scarguard Labs, LLC Expands Distribution Reach Through Agreements With McKesson Drugs and Publix Supermarkets
Date:12/9/2008

GREAT NECK, N.Y., Dec. 9 /PRNewswire/ --Scarguard Labs, LLC, a closely held company specializing in the treatment of scars and other dermatological problems through the use of multi-technology drugs enhanced by a proprietary contact delivery system, announced it has agreements in place with Publix Supermarkets and McKesson Drugs to carry Scarguard products.

"These are very positive developments for Scarguard," said CEO Joel Studin. "McKesson is the largest drug wholesaler in the U.S., with more than 20 distribution centers across the country. Publix is the fourth largest grocery store chain in the U.S., and caters to a high-end clientele through its 450 stores across the Southeast.

"The McKesson agreement complements our existing agreements with Amerisource Bergen and Cardinal Health, and means that we have agreements with the three largest pharmaceutical distributors. This will give our products enormous visibility to retail customers across the country and with large independent drugstores chains in particular. The agreement immediately placed our products in McKesson's two largest retailers, and as a result, we have seen at least a 15% increase in the dollar volume of our sales.

"The Publix clientele is precisely the target market for Scarguard products," continued Studin. "It has been a long time goal of ours to reach an agreement with them. Eventually Publix came to believe that our products are the most efficacious of the category and saw our successes in other food chains such as ShopRite and Pathmark. We consider this agreement to be a highlight of our strategy to increase the retail presence for our products by expanding our presence in other channels."

About Scarguard Labs, LLC

Scarguard Labs, LLC is a closely held pharmaceutical company specializing in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilizing a multi-technology approach. Our flagship product, Scarguard, is the most frequently dispensed product for scars in plastic surgery offices since 2001. In addition, it can be found in most pharmacies, drug distributors and major grocery chains throughout the United States. We have multiple topical prescription and non-prescription drugs in the marketplace, or in varying stages of development For more information, please visit our website at www.scarguard.com.

    Company Contact:                                  Investor Relations:
    Richard E. Pino                                   John McNamara
    Chief Financial Officer/Investor Relations        Cameron Associates
    Scarguard Labs, LLC                               (212) 245-8800 Ext. 205
    516-482-8050                                      john@cameronassoc.com
    Richard@scarguard.com 


'/>"/>
SOURCE Scarguard Labs, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
2. Innovatech Labs, Assisting Companies in Adhering to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment
3. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
4. Rohm and Haas Expands in India
5. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
6. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
7. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
8. Specialty Blades, Inc. Expands Management Team With New VP Engineering
9. CRH Medical expands Las Vegas operations
10. US Med-Equip Expands Corporate Support Center
11. ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased to announce ... a longtime supporter of the event. , "We are pleased that KLS Martin is ... Havlik, 2017 ACPA President. "KLS Martin has a long track record of support of ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare ... for those in the fight against cancer, has produced a seminal study that ... HRA will release top-line findings in a webinar, Defining Compassionate Care Through the ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)... Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... innovative proprietary products for the urology market, will release ... ended December 31, 2016 before the market open on ... will host a conference call and webcast to discuss ... 9, 2017 at 11:00 a.m. Eastern Time (10:00 a.m. ...
Breaking Medicine Technology: